Abstract
In developed countries, the lifetime risk of developing breast cancer among women is 11%. Therefore, screening asymptomatic women for breast cancer is widely accepted as preventive health care. Mammography is the primary imaging modality for the detection of breast abnormalities. Digital breast imaging detects 90% of symptomatic or asymptomatic cancers. The sensitivity, specificity, and negative predictive values of this modality are each about 90%. As a standard of care, the Breast Imaging Reporting and Data System (BI-RADS) is used to quantify increasing degrees of positive predictive values in mammography. This can help clinicians identify abnormalities that may need additional imaging studies or biopsies. To reduce false-negative breast cancer screening results, efforts have focused on increasing the sensitivity of mammography or supplementing it with ultrasound or MRI. Advanced practitioners are strategically positioned to detect incongruities between imaging techniques and physical assessments. With increased knowledge, advanced practitioners are better prepared for shared decision-making discussions regarding follow-up imaging procedures. The case report in this article describes a 10-year discordance of imaging that proved to be high-grade ductal carcinoma in situ (DCIS) and offers a hypothesis of the physiology to explain this discordance. A better understanding of breast imaging will enable the advanced practitioner to recommend the most appropriate follow-up study for patients.
References
Aggarwal, R., Ranganathan, P., & Pramesh, C. S. (2022). Research studies on screening tests. Perspectives in Clinical Research, 13(3), 168–171. https://doi.org/10.4103/picr.picr_111_22
Bakker, M. F., de Lange, S. V., Pijnappel, R. M., Mann, R. M., Peeters, P. H. M., Monninkhof, E. M.,…DENSE Trial Study Group (2019). Supplemental MRI screening for women with extremely dense breast tissue. The New England Journal of Medicine, 381(22), 2091–2102. https://doi.org/10.1056/NEJMoa1903986
Bane, A. (2013). Ductal carcinoma in situ: What the pathologist needs to know and why. International Journal of Breast Cancer, 2013, 914053. https://doi.org/10.1155/2013/914053
Berg, W., Blume, J., Cormack, J., Mendelson, E., Lehrer, D., Böhm-Vélez, M.,…ACRIN 6666 Investigators. (2008). Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA, 299(18), 2151–2163. https://doi.org/10.1001/jama.299.18.2151
Berg, W., Zhang, Z., Lehrer, D., Jong, R., Pisano, E., Barr, R.,…ACRIN 6666 Investigators. (2012). Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA, 307(13), 1394–1404. https://doi.org/10.1001/jama.2012.388
Boca Bene, I., Ciurea, A. I., Ciortea, C. A., & Dudea, S. M. (2021). Pros and cons for automated breast ultrasound (ABUS): A narrative review. Journal of Personalized Medicine, 11(8), 703. https://doi.org/10.3390/jpm11080703
Bragg, A., Candelaria, R., Adrada, B., Huang, M., Rauch, G., Santiago, L., Scoggins, M., & Whitman, G. (2021). Imaging of noncalcified ductal carcinoma in situ. Journal of Clinical Imaging Science, 11, 34. https://doi.org/10.25259/JCIS_48_2021
Comstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T.,…Kuhl, C. K. (2020). Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA, 323(8), 746–756. https://doi.org/10.1001/jama.2020.0572
Durand, M., Friedewald, S., Plecha, D., Copit, D., Barke, L., Rose, S.,…Conant, E. (2021). False-negative rates of breast cancer screening with and without digital breast tomosynthesis. Radiology, 298(2), 296–305. https://doi.org/10.1148/radiol.2020202858
Guirguis, M., Adrada, B., Santiago, L., Candelaria, R., & Arribas, E. (2021). Mimickers of breast malignancy: Imaging findings, pathologic concordance and clinical management. Insights into Imaging, 12(1), 53. https://doi.org/10.1186/s13244-021-00991-x
Institute of Medicine (2011). The future of nursing: Leading change, advancing health. Washington (DC): National Academies Press (US); 2011. 1, Key Messages of the Report. https://www.ncbi.nlm.nih.gov/books/NBK209881/
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D.,…Belay, A. (2022). Global increase in breast cancer incidence: Risk factors and preventive measures. BioMed Research International, 2022, 9605439. https://doi.org/10.1155/2022/9605439
Kerlikowske, K., Su, Y., Sprague, B., Tosteson, A., Buist, D., Onega, T.,…Miglioretti, D. (2022). Association of screening with digital breast tomosynthesis vs digital mammography with risk of interval invasive and advanced breast cancer. JAMA, 327(22), 2220–2230. https://doi.org/10.1001/jama.2022.7672
Kim, J., & Haffty, B. G. (2023). Genetic factors in the screening and imaging for breast cancer. Korean Journal of Radiology, 24(5), 378–383. https://doi.org/10.3348/kjr.2023.0012
Kim, S., Tran, T., & Song, H. (2022). Microcalcifications, mammographic breast density, and risk of breast cancer: A cohort study. Breast Cancer Research, 24, 96. https://doi.org/10.1186/s13058-022-01594-0
Kuhl, C., Schrading, S., Strobel, K., Schild, H., Hilgers, R., & Bieling, H. (2014). Abbreviated breast magnetic resonance imaging (MRI): First postcontrast subtracted images and maximum-intensity projection—A novel approach to breast cancer screening with MRI. Journal of Clinical Oncology, 32(22), 2304–2310. https://doi.org/10.1200/JCO.2013.52.5386
Kunitake, J., Sudilovsky, D., Johnson, L., Loh, H., Choi, S., Morris, P.,…Estroff, L. (2023). Biomineralogical signatures of breast microcalcifications. Science Advances, 9(8), eade3152. https://doi.org/10.1126/sciadv.ade3152
Lehman, C. (2010). Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. Journal of the National Cancer Institute Monographs, 2010(41), 150–151. https://doi.org/10.1093/jncimonographs/lgq030
Lotter, W., Diab, A. R., Haslam, B., Kim, J. G., Grisot, G., Wu, E.,…Sorensen, A. G. (2021). Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach. Nature Medicine, 27(2), 244–249. https://doi.org/10.1038/s41591-020-01174-9
Lunkiewicz, M., Forte, S., Freiwald, B., Singer, G., Leo, C., & Kubik-Huch, R. A. (2020). Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions. European Radiology, 30(1), 77–86. https://doi.org/10.1007/s00330-019-06312-7
Mann, R., Athanasiou, A., Baltzer, P., Camps-Herrero, J., Clauser, P., Fallenberg, E.,…European Society of Breast Imaging. (2022). Breast cancer screening in women with extremely dense breasts: Recommendations of the European Society of Breast Imaging. European Radiology, 32(6), 4036–4045. https://doi.org/10.1007/s00330-022-08617-6
Millet, I., Pages, E., Hoa, D., Merigeaud, S., Curros Doyon, F., Prat, X., & Taourel, P. (2012). Pearls and pitfalls in breast MRI. The British Journal of Radiology, 85(1011), 197–207. https://doi.org/10.1259/bjr/47213729
Nazari, S., & Mukherjee, P. (2018). An overview of mammographic density and its association with breast cancer. Breast Cancer (Tokyo, Japan), 25(3), 259–267. https://doi.org/10.1007/s12282-018-0857-5
Park, C., Jung, N., Kim, K., Jung, H., Sohn, K., & Oh, S. (2013). Detection of breast cancer in asymptomatic and symptomatic groups using computer-aided detection with full-field digital mammography. Journal of Breast Cancer, 16(3), 322–328. https://doi.org/10.4048/jbc.2013.16.3.322
Rahman, W., & Helvie, M. (2022). Breast cancer screening in average and high-risk women. Best Practice & Research: Clinical Obstetrics & Gynaecology, 83, 3–14. https://doi.org/10.1016/j.bpobgyn.2021.11.007
Vidavsky, N., Kunitake, J., & Estroff, L. (2021). Multiple pathways for pathological calcification in the human body. Advanced Healthcare Materials, 10(4), e2001271. https://doi.org/10.1002/adhm.202001271
Vourtsis, A., & Berg, W. (2019). Breast density implications and supplemental screening. European Radiology, 29(4), 1762–1777. https://doi.org/10.1007/s00330-018-5668-8
Wilczek, B., Wilczek, H., Rasouliyan, L., & Leifland, K. (2016). Adding 3D automated breast ultrasound to mammography screening in women with heterogeneously and extremely dense breasts: Report from a hospital-based, high-volume, single-center breast cancer screening program. European Journal of Radiology, 85(9), 1554–1563. https://doi.org/10.1016/j.ejrad.2016.06.004
Wong, S. (2023). Screening for breast cancer in Hodgkin lymphoma survivors. Best Practice & Research: Clinical Haematology, 36(4), 101525. https://doi.org/10.1016/j.beha.2023.101525
Zeeshan, M., Salam, B., Khalid, Q., Alam, S., & Sayani, R. (2018). Diagnostic accuracy of digital mammography in the detection of breast cancer. Cureus, 10(4), e2448. https://doi.org/10.7759/cureus.2448
